We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$540M
AUM Growth
-$17.9M
(-3.2%)
Cap. Flow
-$41M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
716
New
62
Increased
152
Reduced
248
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Malaysia ETF
EWM
|
+$10.3M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$9.74M |
| 3 |
IBM
IBM
|
+$8.96M |
| 4 |
iShares MSCI China ETF
MCHI
|
+$8.57M |
| 5 |
Linde
LIN
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$21.8M |
| 2 |
Stellantis
STLA
|
+$20.9M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$11.4M |
| 4 |
Ferrari
RACE
|
+$10.4M |
| 5 |
Deutsche Bank
DB
|
+$9.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.08% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Technology | 8.88% |
| 4 | Materials | 7.83% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
GrafTech
EAF
$203M
| $81.9K | 0.02% |
701
+63
| +10% | +$7.92K |
|
327
BioMarin Pharmaceuticals
BMRN
$11.6B
| $79.3K | 0.01% |
893
| – | – |
|
328
Allstate
ALL
$67.3B
| $78.5K | 0.01% |
687
+148
| +27% | +$16.2K |
|
329
Autodesk
ADSK
$47.7B
| $77.4K | 0.01% |
406
-6,587
| -94% | -$1.07M |
|
330
NextEra Energy
NEE
$185B
| $76.5K | 0.01% |
+1,216
| New | +$71K |
|
331
Itaú Unibanco
ITUB
$92.3B
| $72.8K | 0.01% |
12,093
-134,776
| -92% | -$844K |
|
332
Estee Lauder
EL
$30.1B
| $70.8K | 0.01% |
324
+260
| +406% | +$50.5K |
|
333
Infosys
INFY
$47.4B
| $67.6K | 0.01% |
6,234
-1,457
| -19% | -$14.7K |
|
|
ORTX
334
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $66.4K | 0.01% |
431
| – | – |
|
335
Crane NXT
CXT
$3.12B
| $66.3K | 0.01% |
2,194
-685
| -24% | -$19.5K |
|
336
iShares MSCI India ETF
INDA
$6.77B
| $66.1K | 0.01% |
1,838
+1,795
| +4,174% | +$61.5K |
|
|
ANSS
337
DELISTED
Ansys
ANSS
| $66.1K | 0.01% |
250
-4,793
| -95% | -$1.13M |
|
338
Ligand Pharmaceuticals
LGND
$5.96B
| $65.7K | 0.01% |
1,154
| – | – |
|
|
AZPN
339
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $65.2K | 0.01% |
465
-8,800
| -95% | -$1.23M |
|
340
Cameco
CCJ
$38.9B
| $64.6K | 0.01% |
7,367
+7,300
| +10,896% | +$67.5K |
|
341
Gen Digital
GEN
$16.1B
| $62.1K | 0.01% |
2,258
-303
| -12% | -$7.4K |
|
342
Micron Technology
MU
$1.02T
| $60.3K | 0.01% |
1,074
-4,860
| -82% | -$232K |
|
343
Opko Health
OPK
$936M
| $59.5K | 0.01% |
38,416
| – | – |
|
344
Royal Bank of Canada
RY
$291B
| $56.4K | 0.01% |
695
| – | – |
|
345
Galicia Financial Group
GGAL
$8.03B
| $51.3K | 0.01% |
+3,462
| New | +$45.7K |
|
346
Comcast
CMCSA
$80.9B
| $51.2K | 0.01% |
1,107
-18,076
| -94% | -$805K |
|
347
Cigna
CI
$77B
| $51K | 0.01% |
245
-1,680
| -87% | -$308K |
|
348
HP
HPQ
$24.3B
| $47.4K | 0.01% |
2,215
-179,244
| -99% | -$3.4M |
|
349
Blue Bird Corp
BLBD
$2.41B
| $46.5K | 0.01% |
2,086
-976
| -32% | -$19.5K |
|
|
LNW
350
DELISTED
Light & Wonder
LNW
| $43K | 0.01% |
1,563
-9,838
| -86% | -$253K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2019 Portfolio in Review
As of Q4 2019, Exane Derivatives held 716 positions worth $540M, down 3.2% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $41M in Q4 2019, closing 35 positions and reducing 248 holdings. Its most notable exit was iShares MSCI Indonesia ETF, an estimated $6.83M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Exane Derivatives opened a new position in IBM worth $9M.
- Exane Derivatives's largest Q4 2019 buy was IBM: 68,905 shares worth $9M.
- Exane Derivatives added most to iShares MSCI Malaysia ETF in Q4 2019, an estimated $10.3M increase.
- Exane Derivatives's biggest Q4 2019 reduction was UBS Group, cutting an estimated $21.8M.
- Exane Derivatives fully exited iShares MSCI Indonesia ETF in Q4 2019, selling an estimated $6.83M.
- Exane Derivatives's ten largest holdings make up 27% of its $540M portfolio in Q4 2019.
- Exane Derivatives opened 62 new positions and closed 35 in Q4 2019.
- Exane Derivatives's portfolio value fell 3.2% quarter-over-quarter to $540M.
Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.